PLUS1
36.66
-0.04 (-0.11%)
-0.04 (-0.11%)
Upgrade to Real-Time
Premarket
Best deals to access real time data! |
|
USA Small Cap Basic
Monthly Subscription
for only
|
|
North American Extreme
Monthly Subscription
for only
|
|
USA Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Stock Name | Stock Symbol | Market | Stock Type |
|---|---|---|---|
| Pfizer Inc | PFE | NYSE | Common Stock |
| Price Change | Price Change % | Stock Price | Last Trade  |
|
|---|---|---|---|---|
| -0.04 | -0.11% | 36.66 | 06:41:08 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 36.70 |
| Trades | Stocks Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 739 | 52,205 | 47,227,753 | 27.88 - 43.0797 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 06:42:25 | 1 | US$ 36.66 | USD |
Pfizer Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| US$ 203.77B | 5.56B | 5.56B | US$ 51.75B | US$ 13.02B | 2.88 | 23.50 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | US$ 1.44 | 3.93% | - | - |
Pfizer News
| Date | Time | Source | News Article |
|---|---|---|---|
| 1/18/2021 | 17:02 | Dow Jones News | New York Seeks to Buy Vaccines Directly From Pfizer --.. |
| 1/18/2021 | 14:53 | Dow Jones News | New York Seeks to Buy Vaccines Directly From Pfizer |
| 1/18/2021 | 12:59 | Dow Jones News | Norway Warns Against Vaccinating the Terminally Ill |
| 1/18/2021 | 12:15 | Dow Jones News | Norway Warns Against Vaccinating the Terminally Ill |
| 1/18/2021 | 11:41 | Dow Jones News | Does Getting the Covid-19 Vaccine Stop You Spreading It?.. |
| 1/15/2021 | 20:38 | Dow Jones News | Biden to Outline Plans for Bigger Federal Role in Covid-19.. |
| 1/15/2021 | 17:19 | Dow Jones News | Biden to Outline Plans for Bigger Federal Role in Covid-19.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PFE Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 37.77 | 37.7859 | 36.40 | 36.91 | 35,691,298 | -1.11 | -2.94% |
| 1 Month | 37.24 | 37.83 | 36.27 | 37.04 | 31,792,906 | -0.58 | -1.56% |
| 3 Months | 37.24 | 43.0797 | 34.60 | 38.28 | 47,457,874 | -0.58 | -1.56% |
| 6 Months | 37.54 | 43.0797 | 33.56 | 37.97 | 34,869,966 | -0.88 | -2.34% |
| 1 Year | 40.41 | 43.0797 | 27.88 | 36.45 | 33,184,737 | -3.75 | -9.28% |
| 3 Years | 37.19 | 46.47 | 8.00 | 38.23 | 25,086,105 | -0.53 | -1.43% |
| 5 Years | 31.12 | 46.47 | 8.00 | 36.26 | 24,051,642 | 5.54 | 17.8% |
Pfizer Description
| Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion. Pfizer also spends a leading amount on research and development, close to $8 billion annually. While Pfizer historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drug Xeljanz. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor. |
